Angiotensin II Type 1 and Type 2 Receptors Regulate Basal Skeletal Muscle Microvascular Volume and Glucose Use
- 1 February 2010
- journal article
- research article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 55 (2), 523-530
- https://doi.org/10.1161/hypertensionaha.109.145409
Abstract
Angiotensin II causes vasoconstriction via the type 1 receptor (AT1R) and vasodilatation through the type 2 receptor (AT2R). Both are expressed in muscle microvasculature, where substrate exchanges occur. Whether they modulate basal muscle microvascular perfusion and substrate metabolism is not known. We measured microvascular blood volume (MBV), a measure of microvascular surface area and perfusion, in rats during systemic infusion of angiotensin II at either 1 or 100 ng/kg per minute. Each caused a significant increase in muscle MBV. Likewise, administration of the AT1R blocker losartan increased muscle MBV by >3-fold (P<0.001). Hindleg glucose extraction and muscle interstitial oxygen saturation simultaneously increased by 2- to 3-fold. By contrast, infusing AT2R antagonist PD123319 significantly decreased muscle MBV by ≥80% (P<0.001). This was associated with a significant decrease in hindleg glucose extraction and muscle oxygen saturation. AT2R antagonism and inhibition of NO synthase each blocked th...Keywords
This publication has 54 references indexed in Scilit:
- Infusing Lipid Raises Plasma Free Fatty Acids and Induces Insulin Resistance in Muscle MicrovasculatureJournal of Clinical Endocrinology & Metabolism, 2009
- The vascular actions of insulin control its delivery to muscle and regulate the rate-limiting step in skeletal muscle insulin actionDiabetologia, 2009
- Role of hypoxia in obesity-induced disorders of glucose and lipid metabolism in adipose tissueAmerican Journal of Physiology-Endocrinology and Metabolism, 2009
- Emerging role of adipose tissue hypoxia in obesity and insulin resistanceInternational Journal of Obesity, 2008
- Hyperinsulinemia Rapidly Increases Human Muscle Microvascular Perfusion but Fails to Increase Muscle Insulin ClearanceDiabetes, 2007
- Regulation of Blood Flow in the MicrocirculationMicrocirculation, 2005
- Angiotensin II Impairs the Insulin Signaling Pathway Promoting Production of Nitric Oxide by Inducing Phosphorylation of Insulin Receptor Substrate-1 on Ser 312 and Ser 616 in Human Umbilical Vein Endothelial CellsCirculation Research, 2004
- Prevention of Type 2 Diabetes Mellitus Through Inhibition of the Renin-Angiotensin SystemDrugs, 2004
- Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels. A potential role for serine phosphorylation in insulin/angiotensin II crosstalk.Journal of Clinical Investigation, 1997
- Insulin transport across capillaries is rate limiting for insulin action in dogs.Journal of Clinical Investigation, 1989